Skip to main content

Table 1 Clinical characteristics comparing treatment success group and treatment failure group

From: Prediction of treatment failure and compliance in patients with tuberculosis

  Treatment success
(N = 50)
Treatment failure
(N = 52)
P-value
Age 44.0(31.5–65) 44.5(29.5–67) 0.84
Male sex 28(56.0%) 38(73.1%) 0.11
BMI 21.1 ± 2.88 20.9 ± 3.07 0.72
Smoking    0.67
 Current 10(20.0%) 13(25.0%)  
 Ex- 10(20.0%) 7(13.5%)  
 Never 30(60.0%) 32(61.5%)  
Drinking    0.21
 Heavy 3(6.0%) 3(5.8%)  
 Social 19(38.0%) 19(36.5%)  
 None 24(48.0%) 30(57.7%)  
Underlying disease
 Diabetes 5(10.0%) 4(26.9%) 0.041
 Lung ds 3(6.0%) 4(7.7%) > 0.99
 Heart ds 1(2.0%) 3(5.8%) 0.24
 Liver ds 2(4.0%) 1(1.9%) > 0.99
 Kidney ds 1(2.0%) 3(5.8%) 0.36
 Prev TB Hx 8(16.0%) 19(36.5%) 0.01
Symptom
 Cough/sputum 20(40.0%) 29(55.8%) 0.16
 Dyspnea 10(20.0%) 7(13.5%) 0.43
 Chest pain 7(14.0%) 3(5.8%) 0.20
 Hemoptysis 1(2.0%) 3(5.8%) 0.62
 Fever 5(10.0%) 3(5.8%) 0.48
 Weakness 0(0%) 1(1.9%) > 0.99
 Weight loss 6(12.0%) 4(7.7%) 0.52
 Asymptomatic 17(34.0%) 15(28.8%) 0.73
Enrollment
 Newly diagnosed 42(84.0%) 29(55.8%)  
 Recurred 8(16.0%) 12(23.1%)  
 Retreatment 0(0%) 7(13.5%)  
 Default 0(0%) 3(5.8%)  
Social Hx
 Occupation 18(36.0%) 23(44.2%) 0.62
 Marriage 28(56.0%) 33(63.5%) 0.13
 Medicaid 6(12.0%) 1(1.9%) 0.06
CPA
 Normal 4(8.0%) 2(3.8%) 0.43
 Cavity (+) 8(17.0%) 26(50.0%) 0.001
 Unilateral 26(52%) 23(44.2%) 0.30
 Bilateral 17(34%) 27(51.9%)  
AFB smear
 Positive 11(23.4%) 27(51.9%)  
DST    < 0.001
 All sensitive 46(92.0%) 21(40.4%)  
 R to INH 2(4.0%) 5(9.6%)  
 R to RFP 1(2.0%) 5(9.6%)  
 Any other R 1(2.0%) 2(3.8%)  
Treatment regimen
 HREZ 38(76.0%) 40(76.9%)  
 HRE 11(22.0%) 1(1.9%)  
 Others 1(2.0%) 11(21.2%)  
Drug compliance
 Good compliance 50(100%) 37(71.2%)  
 Poor compliance 0(0%) 15(28.8%)  
  1. BMI Body mass index, ds Disease, Hx History, R Resistance, INH Isoniazid, RFP Rifampin, MDR Multi-drug resistance